// App-Quantinova.ai

1060 : Clinical Characteristics and Prognosis of Patients with Systemic Sclerosis Sine Scleroderma: Data from the International EUSTAR Database

Researchers

Presenter

  • Alain Lescoat

Principal Investigators

  • Suiyuan Huang

  • PATRICIA E CARREIRA

  • Elise Siegert

  • Jeska de Vries-Bouwstra

  • Jörg Distler

  • Vanessa Smith

  • Branimir Anic

  • Francesco Del Galdo

  • Nemanja Damjanov

  • Simona Rednic

  • camillo Ribi

  • Dominique Farge Bancel

  • Anna-Maria Hoffmann-vold

  • Armando Gabrielli

  • Oliver Distler

  • Dinesh Khanna

  • Yannick Allanore

Medical Centers

  • CHU Rennes - University Rennes 1, Rennes, France

  • University of Michigan, Ann Arbor, MI

  • HOSPITAL 12 DE OCTUBRE, Madrid, Spain

  • Charite Hospital, Berlin, Germany

  • Leiden University Medical Centre, Leiden, Netherlands

  • Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Monash University, Erlangen, Germany

  • Department of Rheumatology, Ghent University Hospital; Department of Internal Medicine, Ghent University; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium

  • Clinical Hospital Centre Zagreb, School of Medicine, University of Zagreb, Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Zagreb, Croatia

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

  • Institute for Endocrinology, Belgrade, Serbia

  • Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania

  • Division of Immunology and Allergy, CHUV, Lausanne, Switzerland

  • Aphp Saint-Louis Hospital, Paris, France

  • Oslo University Hospital, Oslo, Norway

  • Universita Politecnica delle Marche, Ancona, Italy

  • Department of Neuroradiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

  • Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, United States.

  • Dept. of Rheumatology A, Descartes University, APHP, Cochin Hospital, Paris, France, Paris, France

Locations

  • France

  • United States

  • Spain

  • Germany

  • Netherlands

  • Belgium

  • Croatia

  • United Kingdom

  • Serbia

  • Romania

  • Switzerland

  • Norway

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Autoimmune (AI)

  • Genetic Disorder

Disease

  • Scleroderma

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A